![]() |
|
|
Vol. 280, Issue 1, 326-331, 1997
Department of Pharmaceutics, School of Pharmacy, State University
of New York, Buffalo, New York
Because nitroglycerin (NTG, an organic nitrate) and isoamyl nitrite
have similar chemical structures and a common mechanism of vascular
relaxation (i.e., conversion to nitric oxide in vascular tissues and activation of guanylyl cyclase), it has often been assumed
that organic nitrates and nitrites have identical pharmacologic actions. Because recent studies have shown that the vascular enzymes responsible for nitric oxide generation from organic nitrates and
nitrites are distinct, we hypothesized that the in vitro
vascular actions, in vivo hemodynamic effects and
tolerance properties (both in vitro and in
vivo) would be different as well. Isolated blood vessel studies
showed that NTG provided more stable relaxation effects than ISAN, was
more potent and caused greater in vitro vascular
tolerance. Because the mechanism(s) of vascular tolerance in
vitro may not be the same as those occurring in
vivo, we also compared the left ventricular hemodynamic effects
and tolerance properties of NTG vs. isoamyl nitrite and
in congestive heart failure rats. Constant NTG infusion (10 µg/min)
caused initial reductions in left ventricular end-diastolic pressure of
45 to 55%, which returned to baseline within 10 hr (tolerance
development). In contrast, isobutyl nitrite and isoamyl nitrite (45 µg/min) caused inital reductions in left ventricular end-diastolic
pressure similar to NTG (42-58%), but these hemodynamic effects of
organic nitrites were maintained even when infusions were carried out to 22 hr. These results show that organic nitrites and organic nitrates
are not pharmacologically identical (in vitro or
in vivo), and may suggest a therapeutic advantage for
organic nitrites in the treatment of some cardiovascular diseases.
This article has been cited by other articles:
![]() |
C.-M. L. Tseng, M. A. Tabrizi-Fard, and H.-L. Fung Differential Sensitivity among Nitric Oxide Donors toward ODQ-Mediated Inhibition of Vascular Relaxation J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 737 - 742. [Abstract] [Full Text] |
||||
![]() |
S. K. WATTANAPITAYAKUL, D. M. WEINSTEIN, B. J. HOLYCROSS, and J. A. BAUER Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders FASEB J, February 1, 2000; 14(2): 271 - 278. [Abstract] [Full Text] |
||||
![]() |
M. J. Mihm, C. M. Coyle, L. Jing, and J. A. Bauer Vascular Peroxynitrite Formation during Organic Nitrate Tolerance J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 194 - 198. [Abstract] [Full Text] |
||||